Summit Partners Public Asset Management, LLC Jazz Pharmaceuticals PLC Transaction History

Summit Partners Public Asset Management, LLC

$2.79 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$129.72 - $159.85 $11.4 Million - $14 Million	-87,826 Reduced 67.54%	42,214 $6.73 Million
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $1.71 Million - $2.18 Million	13,524 Added 11.61%	130,040 $17.3 Million
Q2 2022 Aug 15, 2022	BUY	$141.59 - $168.66 $16.5 Million - $19.7 Million	116,516 New	116,516 $18.2 Million
Q4 2018 Feb 14, 2019	SELL	$115.94 - $166.74 $16.2 Million - $23.3 Million	-139,893 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$161.01 - $180.57 $8.03 Million - $9.01 Million	49,893 Added 55.44%	139,893 $23.5 Million
Q2 2018 Aug 14, 2018	SELL	$146.33 - $183.18 $2.93 Million - $3.66 Million	-20,000 Reduced 18.18%	90,000 $15.5 Million
Q1 2018 May 15, 2018	BUY	$135.59 - $157.16 $14.9 Million - $17.3 Million	110,000 New	110,000 $16.6 Million

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Partners Public Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Partners Public Asset Management, LLC with notifications on news.

Account